AU2001236685A1 - Preparation of aqueous clear solution dosage forms with bile acids - Google Patents

Preparation of aqueous clear solution dosage forms with bile acids

Info

Publication number
AU2001236685A1
AU2001236685A1 AU2001236685A AU2001236685A AU2001236685A1 AU 2001236685 A1 AU2001236685 A1 AU 2001236685A1 AU 2001236685 A AU2001236685 A AU 2001236685A AU 2001236685 A AU2001236685 A AU 2001236685A AU 2001236685 A1 AU2001236685 A1 AU 2001236685A1
Authority
AU
Australia
Prior art keywords
preparation
dosage forms
clear solution
bile acids
solution dosage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2001236685A
Other versions
AU2001236685B2 (en
Inventor
Seo Hong Yoo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority claimed from PCT/US2001/003745 external-priority patent/WO2001056547A2/en
Publication of AU2001236685A1 publication Critical patent/AU2001236685A1/en
Application granted granted Critical
Publication of AU2001236685B2 publication Critical patent/AU2001236685B2/en
Priority to AU2006203315A priority Critical patent/AU2006203315B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2001236685A 2000-02-04 2001-02-05 Preparation of aqueous clear solution dosage forms with bile acids Ceased AU2001236685B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2006203315A AU2006203315B2 (en) 2000-02-04 2006-08-03 Preparation of aqueous clear solution dosage forms with bile acids

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18026800P 2000-02-04 2000-02-04
US60/180,268 2000-02-04
PCT/US2001/003745 WO2001056547A2 (en) 2000-02-04 2001-02-05 Preparation of aqueous clear solution dosage forms with bile acids

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2006203315A Division AU2006203315B2 (en) 2000-02-04 2006-08-03 Preparation of aqueous clear solution dosage forms with bile acids

Publications (2)

Publication Number Publication Date
AU2001236685A1 true AU2001236685A1 (en) 2001-10-25
AU2001236685B2 AU2001236685B2 (en) 2006-05-18

Family

ID=22659829

Family Applications (2)

Application Number Title Priority Date Filing Date
AU3668501A Pending AU3668501A (en) 2000-02-04 2001-02-05 Preparation of aqueous clear solution dosage forms with bile acids
AU2001236685A Ceased AU2001236685B2 (en) 2000-02-04 2001-02-05 Preparation of aqueous clear solution dosage forms with bile acids

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU3668501A Pending AU3668501A (en) 2000-02-04 2001-02-05 Preparation of aqueous clear solution dosage forms with bile acids

Country Status (11)

Country Link
US (1) US7166299B2 (en)
EP (1) EP1255566A2 (en)
JP (1) JP2004500378A (en)
KR (1) KR100848344B1 (en)
CN (1) CN100558407C (en)
AU (2) AU3668501A (en)
BR (1) BR0108080A (en)
CA (1) CA2406930C (en)
IL (2) IL150952A0 (en)
RU (1) RU2277913C2 (en)
WO (1) WO2001056547A2 (en)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070072828A1 (en) * 1998-07-24 2007-03-29 Yoo Seo H Bile preparations for colorectal disorders
US7772220B2 (en) * 2004-10-15 2010-08-10 Seo Hong Yoo Methods and compositions for reducing toxicity of a pharmaceutical compound
US7303768B2 (en) * 1998-07-24 2007-12-04 Seo Hong Yoo Preparation of aqueous clear solution dosage forms with bile acids
US20050158408A1 (en) * 1998-07-24 2005-07-21 Yoo Seo H. Dried forms of aqueous solubilized bile acid dosage formulation: preparation and uses thereof
CA2426925A1 (en) * 2000-11-24 2003-04-25 Yamanouchi Pharmaceutical Co., Ltd. Water-soluble liquid internal medicine
KR20030082053A (en) * 2002-04-16 2003-10-22 진갑덕 Composite for toothpaste
AU2003900096A0 (en) * 2003-01-10 2003-02-20 Nature Vet Orally deliverable pharmaceutical composition protein pump inhibitors
US7145125B2 (en) 2003-06-23 2006-12-05 Advanced Optical Technologies, Llc Integrating chamber cone light using LED sources
US20050053664A1 (en) 2003-09-08 2005-03-10 Eliezer Zomer Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer
EP2422789B1 (en) * 2004-05-19 2017-11-22 Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center Injectable coposition comprising sodium deoxycholate
US7754230B2 (en) * 2004-05-19 2010-07-13 The Regents Of The University Of California Methods and related compositions for reduction of fat
US20060127468A1 (en) 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
JP2008511651A (en) * 2004-08-30 2008-04-17 セオ ホン ユー Neuroprotective effect of solubilized UDCA in a local ischemia model
BRPI0518191A (en) 2004-10-15 2008-11-04 Seo Hong Yoo methods and compositions for reducing the toxicity of a pharmaceutical compound
ES2358089T3 (en) * 2004-11-01 2011-05-05 Seo Hong Yoo METHODS AND COMPOSITIONS TO REDUCE NEURODEGENERATION IN AMIOTROPHIC SIDE STERHERISIS.
CA2585471A1 (en) * 2004-11-01 2006-05-11 Seo Hong Yoo Methods and compositions for reducing neurodegeneration in amyotrophic lateral sclerosis
AU2004325203A1 (en) * 2004-11-24 2006-06-01 Seo Hong Yoo Dried forms of aqueous solubilized bile acid dosage formulation: preparation and uses thereof
WO2007022105A2 (en) 2005-08-12 2007-02-22 Rubicon Research Pvt. Ltd. Stable pharmaceutical compositions, processes for making the same, and methods of their use
WO2008011216A2 (en) 2006-05-16 2008-01-24 Pro-Pharmaceuticals, Inc. Galactose-pronged polysaccharides in a formulation for antifibrotic therapies
JP2010503667A (en) * 2006-09-15 2010-02-04 ホン ユー，ソ Bile preparation for colorectal disease
US8242294B2 (en) 2007-06-19 2012-08-14 Kythera Biopharmaceuticals, Inc. Synthetic bile acid compositions and methods
US20080318870A1 (en) 2007-06-19 2008-12-25 Kythera Biopharmaceuticals, Inc. Synthetic bile acid compositions and methods
JOP20180077A1 (en) 2007-06-19 2019-01-30 Kythera Biopharmaceuticals Inc Synthetic bile acid compositions and methods
BRPI0822449A2 (en) 2008-03-04 2015-06-16 Aleksander Vladimirovich Dikovskiy Hepatoprotective and prebiotic based pharmaceutical composition, production and use of this
US8101593B2 (en) 2009-03-03 2012-01-24 Kythera Biopharmaceuticals, Inc. Formulations of deoxycholic acid and salts thereof
GB2480632A (en) 2010-05-25 2011-11-30 Kythera Biopharmaceuticals Inc Preparation of 12-keto and 12-alpha-hydroxy steroids
US10150792B2 (en) 2010-11-08 2018-12-11 Synthonics, Inc. Bismuth-containing compounds, coordination polymers, methods for modulating pharmacokinetic properties of biologically active agents, and methods for treating patients
MX363465B (en) 2011-02-18 2019-03-25 Kythera Biopharmaceuticals Inc Treatment of submental fat.
US8653058B2 (en) 2011-04-05 2014-02-18 Kythera Biopharmaceuticals, Inc. Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits
EP2755480B1 (en) * 2011-09-16 2021-03-31 Galectin Therapeutics Inc. Galacto-rhamnogalacturonate compositions for the treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease
DK2758060T3 (en) * 2011-09-19 2018-03-05 Eth Zuerich ROR gamma modulators for the treatment of diabetes II complications
EP2606747A1 (en) * 2011-12-22 2013-06-26 Nutrinova Nutrition Specialties & Food Ingredients GmbH Sweetness enhancer, sweetener compositions, and consumables containing the same
CN103169650A (en) * 2012-03-28 2013-06-26 沈阳津昌制药有限公司 Anti-flu syrup and preparation method thereof
BR112014030534A2 (en) 2012-06-06 2017-06-27 Galectin Therapeutics Inc galacto-ramnogalacturonate compositions for the treatment of diseases associated with high inducible nitric oxide synthase
KR102064890B1 (en) * 2013-10-22 2020-02-11 삼성전자 주식회사 Device for processing HARQ data selectively using internal and external memories, and Method there-of
CN104546695A (en) * 2013-10-25 2015-04-29 北京韩美药品有限公司 Oral Montelukast sodium liquid preparation and preparation method thereof
EP3082428A4 (en) 2013-12-09 2017-08-02 Respira Therapeutics, Inc. Pde5 inhibitor powder formulations and methods relating thereto
NO2723977T3 (en) 2014-03-19 2018-03-10
CN114224829A (en) 2014-06-27 2022-03-25 玫帝托克斯股份有限公司 Preparation of cholic acid and salt for reducing fat and application thereof
WO2016070082A1 (en) 2014-10-31 2016-05-06 University Of Utah Research Foundation Compositions and methods for bile acid particles
IL293439A (en) * 2016-02-29 2022-07-01 Tel Hashomer Medical Res Infrastructure & Services Ltd Use of bile acids and bile salts as anti bacterial agents for inhibition of bacterial conjugation and horizontal gene transfer
KR20180036580A (en) * 2016-09-30 2018-04-09 주식회사 유스바이오팜 Composition for prevention or treatment of inflammatory skin diseases or severe pruritus comprising the aqueous solubilized ursodeoxycholic acid
CN106619670A (en) * 2016-12-17 2017-05-10 郑州郑先医药科技有限公司 Western medicine compound for treating stomachache
KR102252450B1 (en) * 2017-02-09 2021-05-14 주식회사 아미코젠파마 Composition for prevention or treatment of visual disorders comprising ursodeoxycholic acid
US9989519B1 (en) * 2017-05-04 2018-06-05 Clayton Pharmaceuticals, LLC Method for determining in vitro bioequivalence of a sucralfate suspension sample to a sucralfate suspension reference listed drug (RLD)
CN110730656B (en) * 2017-06-02 2022-09-16 特一华制药株式会社 Sparingly water-soluble component-solubilizing micelle and liquid preparation containing the same
CN108685919A (en) * 2018-07-23 2018-10-23 卡梅德生物科技（天津）有限公司 Omeprazole is used to prepare the application of liver-cancer stem cell inhibitor
KR102111346B1 (en) * 2019-08-20 2020-05-22 아영창 Aqueous composition with sodium deoxycholate having improved stability against precipitation
EP4021492A4 (en) * 2019-08-30 2023-09-06 Emory University Use of deoxycholic acid, derivatives, or salts thereof in managing bacterial infections and compositions related thereto
WO2022060121A1 (en) * 2020-09-18 2022-03-24 주식회사 아미코젠파마 Pharmaceutical composition for preventing or treating sepsis, acute lung injury, or acute respiratory distress syndrome, containing water-solubilized bile acid

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4320146A (en) 1978-03-17 1982-03-16 The Johns Hopkins University Treatment of hepatic and renal disorders with ornithine and arginine salts of branched chain keto acids
JPS5522616A (en) * 1978-08-04 1980-02-18 Tokyo Tanabe Co Ltd Bile acid inclusion compound and injection containing the same
US4327725A (en) 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
IT1210874B (en) * 1982-04-15 1989-09-29 Istituto Chemioterapico MAGNESIUM SALT OF KENODEXOXYLIC ACID AND URSODEXOXYLIC ACID, PROCESS FOR LASUAL PREPARATION AND THERAPEUTIC COMPOSITIONS THAT CONTAIN IT AS AN ACTIVE INGREDIENT.
IT1152801B (en) * 1982-08-17 1987-01-14 Proter Spa STEROID COMPOUNDS FOR CHOLERETIC ACTIVITY, PROCESS FOR THEIR PREPARATION AND THERAPEUTIC COMPOSITIONS THAT CONTAIN THEM AS AN ACTIVE PRINCIPLE
GB8313217D0 (en) 1983-05-13 1983-06-22 Glaxo Group Ltd Pharmaceutical compositions
GB8417895D0 (en) 1984-07-13 1984-08-15 Marples B A Pharmaceutical anti-fungal composition
JPS62153220A (en) * 1985-12-27 1987-07-08 Tokyo Tanabe Co Ltd Water-based bile acid agent for internal use
US4999287A (en) * 1988-05-19 1991-03-12 Chemtrak Corporation Direct measuring assay strip and method of use thereof
HU203204B (en) 1987-09-15 1991-06-28 Sandoz Ag Process for producing suppository containing calcitonin and taurocholic acid
CA1336401C (en) 1987-10-15 1995-07-25 Brian H. Vickery Intranasal administration of polypeptides in powdered form
US5446026A (en) 1989-08-09 1995-08-29 Advanced Peptides & Biotechnology Sciences Potent non-opiate analgesic
US5157022A (en) 1989-11-22 1992-10-20 Adrian Barbul Method for reducing blood cholesterol using arginine
EP0527153B1 (en) 1990-04-04 1996-07-24 Berwind Pharmaceutical Services, Inc. Aqueous maltodextrin and cellulosic polymer film coatings
US5057321A (en) 1990-06-13 1991-10-15 Alza Corporation Dosage form comprising drug and maltodextrin
US5269011A (en) * 1990-09-24 1993-12-07 Emc Corporation Dynamically reconfigurable data storage system with storage system controllers selectively operable as channel adapters on storage device adapters
IT1245889B (en) 1991-04-12 1994-10-25 Alfa Wassermann Spa PHARMACEUTICAL FORMULATIONS FOR ORAL USE GAS RESISTANT CONTAINING SALTS OF BILE ACIDS.
IT1245890B (en) 1991-04-12 1994-10-25 Alfa Wassermann Spa PHARMACEUTICAL FORMULATIONS FOR ORAL USE GASTRORESANTS CONTAINING BILE ACIDS.
IT1245891B (en) 1991-04-12 1994-10-25 Alfa Wassermann Spa CONTROLLED RELEASE PHARMACEUTICAL FORMULATIONS FOR ORAL USE GAS RESISTANT CONTAINING BILE ACIDS AND THEIR SALTS.
CH680704A5 (en) 1991-05-15 1992-10-30 Medichemie Ag
HU209251B (en) 1992-03-13 1994-04-28 Synepos Ag Process for producing stable, peroral solution drug forms with controlled release of active ingredient and comprising beta-blocking pharmacons
GB9212511D0 (en) * 1992-06-12 1992-07-22 Cortecs Ltd Pharmaceutical compositions
US5302400A (en) 1992-06-22 1994-04-12 Digestive Care Inc. Preparation of gastric acid-resistant microspheres containing digestive enzymes and buffered-bile acids
US5260074A (en) 1992-06-22 1993-11-09 Digestive Care Inc. Compositions of digestive enzymes and salts of bile acids and process for preparation thereof
US5578304A (en) 1992-06-22 1996-11-26 Digestive Care Inc. Compositions of digestive enzymes and salts of bile acids and process for preparation thereof
US5977070A (en) * 1992-07-14 1999-11-02 Piazza; Christin Teresa Pharmaceutical compositions for the nasal delivery of compounds useful for the treatment of osteoporosis
AU683049B2 (en) 1993-03-31 1997-10-30 Mitsubishi-Tokyo Pharmaceuticals, Inc. Cholestasis ameliorant
CA2167537A1 (en) 1993-07-19 1995-02-02 Tsuneo Ozeki Hepatitis c virus proliferation inhibitor
DE59407041D1 (en) * 1993-08-30 1998-11-12 Medichemie Ag Medicinal product containing ursodeoxycholic acid in liquid dosage form
JP3288550B2 (en) * 1994-05-02 2002-06-04 オーバーシーズ ファーマテック株式会社 Oral topical formulation for killing Helicobacter pylori
DE4432708A1 (en) 1994-09-14 1996-03-21 Hoechst Ag Modified bile acids, process for their preparation and their use
US5653987A (en) 1995-05-16 1997-08-05 Modi; Pankaj Liquid formulations for proteinic pharmaceuticals
DE19523204A1 (en) * 1995-06-27 1997-01-02 Hoechst Ag Powdered pigment preparation
US5686588A (en) 1995-08-16 1997-11-11 Yoo; Seo Hong Amine acid salt compounds and process for the production thereof
US5843929A (en) 1996-03-22 1998-12-01 Mayo Foundation For Medical Education And Research Chemoprevention of metachronous adenomatous colorectal polyps
AU2540397A (en) 1996-03-22 1997-10-10 Mayo Foundation For Medical Education And Research Combinations of an ursodeoxycholic acid compound and a nsaid for the chemopreventive protection of the colorectum
DE29717252U1 (en) 1997-09-26 1998-02-19 Dr. Falk Pharma GmbH, 79108 Freiburg Drug kit consisting of a budesonide-containing and an ursodeoxycholic acid-containing drug for the treatment of cholestatic liver diseases
KR100572090B1 (en) * 1998-02-24 2006-04-17 액티브 바이오틱스 인코포레이티드 Antimicrobial compositions with synergistic effect, drugs and remedies for digestive diseases containing the same, process for the production thereof and preparations associated therewith
RU2224523C2 (en) * 1998-07-24 2004-02-27 Сео Хонг Ю Bile acid-containing aqueous solution and method for its preparing

Similar Documents

Publication Publication Date Title
AU2001236685A1 (en) Preparation of aqueous clear solution dosage forms with bile acids
AU3668501A (en) Preparation of aqueous clear solution dosage forms with bile acids
IL154031A0 (en) Substituted sulfonylaminomethylbenzoic acid derivatives and preparation
AU2001252638A1 (en) Process for the preparation of 2-halobenzoic acids
AU2002318091A1 (en) Taste masked aqueous liquid pharmaceutical composition
AU2001278471A1 (en) Stable salts of o-acetylsalicyclic with basic amino acids
AU1548001A (en) Ophthalmic aqueous preparation
AU2001267854A1 (en) Novel dicarboxylic acid derivatives
AU2002224884A1 (en) Substituted anthranilic acids
AU2001273761A1 (en) Preparation of (r)-2-alkyl-3-phenylpropionic acids
AU2001280167A1 (en) Novel propenohydroxamic acid derivatives
AU2001248833A1 (en) Stable liquid preparation
AU2002214978A1 (en) Beta-Thio-amino acids
PL338844A1 (en) Stable aqueous solution of lysine
AU2001284763A1 (en) Preparation of risperidone
HUP0103788A3 (en) Processes for the preparation of 5-hydroxy-3-oxopentanoic acid derivatives
AU2001242376A1 (en) Process for the preparation of 2-hydroxy-4-methylthiobutyric acid esters
AU2001286163A1 (en) An improved process for the preparation of 3-aryl-2-hydroxy propanoic acid derivatives
AU2233001A (en) Preparation method of methacrylic acid
AU2001286477A1 (en) Process for the preparation of water soluble polypyrrole
AU7958000A (en) Process for the preparation of oxyiminoalkanoic acid derivatives
AU3445400A (en) The preparation of (trans)-4-amino-2-cyclopentene-1-carboxylic acid derivatives
AU2001252146A1 (en) Process for the preparation of glycidylesters of branched carboxylic acids
GB0019593D0 (en) Production of bile acid derivatives
AU2001273189A1 (en) Process for the preparation of derivatives of 4-amino-3-hydroxypyrrole-2-carboxylic acid